Cases 21 - 30 of 53
Azurity Pharmaceuticals, Inc. et al v. Alkem Laboratories Ltd.
as 1:2022cv00940
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Alkem Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Duchesnay Inc. v. Alkem Laboratories Ltd.
as 1:2022cv00917
Plaintiff:
Duchesnay Inc.
Defendant:
Alkem Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARBOR PHARMACEUTICALS, LLC v. ALKEM LABORATORIES LTD.
as 1:2022cv00143
Plaintiff:
ARBOR PHARMACEUTICALS, LLC
Defendant:
ALKEM LABORATORIES LTD.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2022cv00032
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd. and S&B Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARBOR PHARMACEUTICALS, LLC v. ALKEM LABORATORIES LTD.
as 2:2022cv00143
Plaintiff:
ARBOR PHARMACEUTICALS, LLC
Defendant:
ALKEM LABORATORIES LTD.
Cause Of Action: 15 U.S.C. § 1126
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
